MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/2159-8290.cd-12-0421

Медицинская библиотека · Cancer discovery · 2012

Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.

Domchek Susan M, Tang Jiangbo, Stopfer Jill, Lilli Dana R, Hamel Nancy, Tischkowitz Marc, Monteiro Alvaro N A, Messick Troy E, Powers Jacquelyn, Yonker Alexandria, Couch Fergus J, Goldgar David E, Davidson H Rosemarie, Nathanson Katherine L, Foulkes William D, Greenberg Roger A

Клинический случайСтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПоддержка правительства СШАПеревод в очереди

Аннотация

UNLABELLED: BRCA1 and BRCA2 are the most important breast and ovarian cancer susceptibility genes. Biallelic mutations in BRCA2 can lead to Fanconi anemia and predisposition to cancers, whereas biallelic BRCA1 mutations have not been confirmed, presumably because one wild-type BRCA1 allele is required during embryogenesis. This study describes an individual who was diagnosed with ovarian carcinoma at age 28 and found to have one allele with a deleterious mutation in BRCA1, c.2457delC (p.Asp821Ilefs*25), and a second allele with a variant of unknown significance in BRCA1, c.5207T>C (p.Val1736Ala). Medical records revealed short stature, microcephaly, developmental delay, and significant toxicity from chemotherapy. BRCA1 p.Val1736Ala cosegregated with cancer in multiple families, associated tumors showed loss of wild-type BRCA1, and BRCA1 p.Val1736Ala showed reduced DNA damage localization. These findings represent the first validated example of biallelic deleterious human BRCA1 mutations and have implications for the interpretation of genetic test results.

SIGNIFICANCE: Accurate assessment of genetic testing data for BRCA1 mutations is essential for clinical monitoring and treatment strategies. Here, we report the fi rst validated example of an individual with biallelic BRCA1 mutations, early-onset ovarian cancer, and clinically significant hypersensitivity to chemotherapy.

Для цитирования: Domchek Susan M, Tang Jiangbo, Stopfer Jill, Lilli Dana R, Hamel Nancy, Tischkowitz Marc, Monteiro Alvaro N A, Messick Troy E, Powers Jacquelyn, Yonker Alexandria, Couch Fergus J, Goldgar David E, Davidson H Rosemarie, Nathanson Katherine L, Foulkes William D, Greenberg Roger A. Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.. Cancer discovery. 2012. DOI: 10.1158/2159-8290.cd-12-0421.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.